LNSR · NASDAQ · Medical - Devices

LENSAR (LNSR)

Builds cataract laser systems and earns recurring revenue from procedures, leases, service, and consumables.

$7.25
After hours+0.06 (+0.83%)
At close$7.19(−0.28%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue101211131417141414161316
Cost of revenue5756710779977
Gross profit5557677767610
7888781313131248
Research & development211111211111
5677671112121036
General & administrative000000000036
Other expenses000000000000
Operating income−2−3−3−2−1−1−6−6−8−522
5−11−70−17−22543341
Interest income000000000000
Other non-operating income01−1701722−5−4−3−341
Income before tax3−4−2−9−2−19−27−2−4−1364
Net income from continuing operations3−4−2−9−2−19−27−2−4−1364
Net income3−4−2−9−2−19−27−2−4−1364
EPS, basic$0.23−$0.35−$0.19−$0.79−$0.13−$1.61−$2.32−$0.15−$0.31−$0.12$1.56$0.14
EPS, diluted$0.21−$0.35−$0.19−$0.79−$0.13−$1.61−$2.32−$0.15−$0.31−$0.12$0.00$0.10
Weighted average shares, basic111111111212121212121212
Weighted average shares, diluted121111111212121212121523
EBITDA−1−3−1−80−18−26−1−30371
Depreciation & amortization111111111110
EBIT−2−4−2−9−1−19−27−2−4−1361